Cargando…

Author Correction: Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Acevedo, Mónica L., Gaete-Argel, Aracelly, Alonso-Palomares, Luis, de Oca, Marco Montes, Bustamante, Andrés, Gaggero, Aldo, Paredes, Fabio, Cortes, Claudia P., Pantano, Sergio, Martínez-Valdebenito, Constanza, Angulo, Jenniffer, Le Corre, Nicole, Ferrés, Marcela, Navarrete, Marcelo A., Valiente-Echeverría, Fernando, Soto-Rifo, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9125951/ https://www.ncbi.nlm.nih.gov/pubmed/35606424 http://dx.doi.org/10.1038/s41564-022-01154-4

Ejemplares similares

Author Correction: Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile
por: Acevedo, Mónica L., et al.
Publicado: (2023)

Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
por: Acevedo, Johanna, et al.
Publicado: (2023)

Neutralizing antibody titers elicited by CoronaVac and BNT162b2 vaccines in health care workers with and without prior SARS-CoV-2 infection
por: Wolff, Marcelo J, et al.
Publicado: (2022)

Strategies for Success. Viral Infections and Membraneless Organelles
por: Gaete-Argel, Aracelly, et al.
Publicado: (2019)

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
por: Schultz, Bárbara M., et al.
Publicado: (2022)

Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile
por: Beltrán-Pavez, Carolina, et al.
Publicado: (2021)

Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner
por: Abreu, Cecilia, et al.
Publicado: (2023)

Characterization of Oral Immunity in Cases and Close Household Contacts Exposed to Andes Orthohantavirus (ANDV)
por: Martinez-Valdebenito, Constanza, et al.
Publicado: (2020)

N(6) -Methyladenosine Negatively Regulates Human Respiratory Syncytial Virus Replication
por: Figueroa, Fabian, et al.
Publicado: (2021)

Monkeypox Virus in Wastewater Samples from Santiago Metropolitan Region, Chile
por: Ampuero, Manuel, et al.
Publicado: (2023)

Tellurite Promotes Stress Granules and Nuclear SG-Like Assembly in Response to Oxidative Stress and DNA Damage
por: Gaete-Argel, Aracelly, et al.
Publicado: (2021)

Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients
por: Gaete-Argel, Aracelly, et al.
Publicado: (2023)

Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group
por: Escobar, Alejandro, et al.
Publicado: (2022)

Serological study of CoronaVac vaccine and booster doses in Chile: immunogenicity and persistence of anti-SARS-CoV-2 spike antibodies
por: Vargas, Leonardo, et al.
Publicado: (2022)

Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023)

Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022)

A Rev–CBP80–eIF4AI complex drives Gag synthesis from the HIV-1 unspliced mRNA
por: Toro-Ascuy, Daniela, et al.
Publicado: (2018)

CoronaVac efficacy data from Turkey
por: McMenamin, Martina E, et al.
Publicado: (2021)

COVID-19 lateral flow IgG seropositivity and serum neutralising antibody responses after primary and booster vaccinations in Chile: a cross-sectional study
por: Sauré, Denis, et al.
Publicado: (2023)

A Randomized Clinical Trial Using CoronaVac or BNT162b2 Vaccine as a Third Dose in Adults Vaccinated with Two Doses of CoronaVac
por: Mok, Chris Ka Pun, et al.
Publicado: (2022)

CoronaVac or BNT162b2 Vaccine as a Third Dose
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

CoronaVac: more data for regulators and policy makers
por: Ramasamy, Maheshi N, et al.
Publicado: (2021)

Minimal change disease following vaccination with CoronaVac
por: Dirim, Ahmet Burak, et al.
Publicado: (2021)

Humoral Immune Response to CoronaVac in Turkish Adults
por: Cosgun, Yasemin, et al.
Publicado: (2023)

ANCA-associated vasculitis following the CoronaVac vaccination
por: Ma, Yaohui, et al.
Publicado: (2022)

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial
por: Li, Jingxin, et al.
Publicado: (2022)

BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac
por: Erol, Çiğdem, et al.
Publicado: (2023)

Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil
por: Cerqueira-Silva, Thiago, et al.
Publicado: (2022)

Effectiveness of the BNT162b2 and the CoronaVac vaccines and boosters in healthcare workers
por: Çulpan, Hazal Cansu, et al.
Publicado: (2023)

Assessment of Mutations Associated With Genomic Variants of SARS-CoV-2: RT-qPCR as a Rapid and Affordable Tool to Monitoring Known Circulating Variants in Chile, 2021
por: Angulo, Jenniffer, et al.
Publicado: (2022)

A Single-Nucleotide Polymorphism of α(V)β(3) Integrin Is Associated with the Andes Virus Infection Susceptibility
por: Martínez-Valdebenito, Constanza, et al.
Publicado: (2019)

Epitranscriptomic regulation of HIV-1 full-length RNA packaging
por: Pereira-Montecinos, Camila, et al.
Publicado: (2022)

Accuracy of a RT-qPCR SARS-CoV-2 detection assay without prior RNA extraction
por: Beltrán-Pavez, Carolina, et al.
Publicado: (2021)

CoronaVac efficacy data from Turkey – Authors' reply
por: Tanriover, Mine Durusu, et al.
Publicado: (2021)

Leukocytoclastic vasculitis after the third dose of CoronaVac vaccination
por: Oskay, T., et al.
Publicado: (2021)

Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers
por: Bayhan, Gulsum Iclal, et al.
Publicado: (2022)

Antibody dynamics post-Comirnaty and CoronaVac vaccination in Malaysia
por: Tan, Cheng Siang, et al.
Publicado: (2022)

Cutaneous reactions after CoronaVac and BioNTech vaccines
por: Öner, Ümran, et al.
Publicado: (2022)

Evaluation and follow-up of antibody formation after CoronaVac vaccine
por: Çalişir, Büşra, et al.
Publicado: (2022)

Phenotypic and functional changes of T cell subsets after CoronaVac vaccination
por: Phoksawat, Wisitsak, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djml72hm3ofvle5jd1e5iphlvt